Related Experiment Video
Updated: Feb 8, 2026

Focal Laser Ablation of Prostate Cancer: An Office Procedure
Published on: March 30, 2021
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic
Stephanie Guillaumier1, Max Peters2, Manit Arya3
1Division of Surgery and Interventional Sciences, University College London, London, UK; Department of Urology, UCLH NHS Foundation Trust, London, UK.
Focal high-intensity focused ultrasound (HIFU) therapy offers effective medium-term control for select prostate cancer patients, with an 88% failure-free survival at 5 years and minimal side effects. This approach shows promise for treating localized prostate cancer with reduced impact.
Area of Science:
- Urology
- Oncology
- Medical Technology
Background:
- Clinically significant nonmetastatic prostate cancer (PCa) is often treated with whole-gland therapies, which can lead to urinary, sexual, and rectal side effects.
- Focal therapy presents an alternative by targeting only cancerous areas within the prostate.
Purpose of the Study:
- To evaluate the 5-year prostate cancer control rates following focal high-intensity focused ultrasound (HIFU) therapy.
- To assess the efficacy and side effect profile of focal HIFU for localized prostate cancer.
Main Methods:
- A prospective study involved 625 patients with nonmetastatic clinically significant PCa undergoing focal HIFU between 2006 and 2015.
- Disease localization utilized multiparametric MRI (mpMRI) and biopsies; treatment targeted significant disease areas.
- Follow-up included PSA monitoring, mpMRI, and biopsies to assess outcomes.
Main Results:
- At 5 years, failure-free survival (FFS) was 88%. Metastasis-free, cancer-specific, and overall survival rates were 98%, 100%, and 99%, respectively.
- Only 2% of patients experienced any pad use for urinary incontinence, indicating a low rate of side effects.
- The median follow-up was 56 months, with most patients (84%) having intermediate- or high-risk PCa.
Conclusions:
- Focal HIFU therapy is an effective medium-term treatment option for select patients with clinically significant nonmetastatic prostate cancer.
- The procedure demonstrates a low probability of side effects, particularly urinary incontinence, compared to traditional whole-gland treatments.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
5-Number Summary
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Predicting Reaction Outcomes

